Is IGF-1 LR3 Legal? FDA, Compounding and WADA Status
IGF-1 LR3's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.
- FDA status
- Not approved
- research chemical
- PCAC vote
- Not reviewed
- not on the Jul 2026 PCAC agenda
- WADA
- Prohibited (S2.3)
- In and out of competition
Current status
Not FDA approved · research chemicalNo. IGF-1 LR3 is not FDA approved for any use.
| Country | Status | Source |
|---|---|---|
| United States | No approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "IGF-1 LR3" returned no matches on 2 Oct 2026. | api.fda.govchecked 2 Oct 2026 |
Timeline
Compounding and research-use sellers
- Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
- The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
- "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
Sport and drug testing
Prohibited by WADA (S2.3)IGF-1 and its analogues (LR3 is an IGF-1 analogue) are prohibited in S2.3, at all times.
Outside the US
Rules differ by country. What each regulator's own records show, with the date we checked:
| Country | Status | Source |
|---|---|---|
| United Kingdom | No approved product foundNo approved product found in an emc (UK SmPC compendium) search for "IGF-1 LR3" on 2 Oct 2026. | medicines.org.ukchecked 2 Oct 2026 |
| Canada | No approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "IGF-1 LR3" on 2 Oct 2026. | health-products.canada.cachecked 2 Oct 2026 |
| Australia | No approved product foundNo approved product found in an ARTG search for "IGF-1 LR3" on 2 Oct 2026. | tga.gov.auchecked 2 Oct 2026 |
| European Union | No centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026 | ema.europa.euchecked 2 Oct 2026 |
What regulator databases show for IGF-1 LR3
The openFDA Drugs@FDA search for IGF-1 LR3 as an active ingredient found no application.[2]
Health Canada's drug product database returned no active-ingredient records for IGF-1 LR3.[4]
The Australian Register of Therapeutic Goods search for IGF-1 LR3 had no matching results.[5]
The UK emc search for IGF-1 LR3 returned no search results.[3]
How a review frames its status
A narrative review says there is no regulatory approval for physique- or performance-related indications, with product composition, dose and stacking uncertain in unregulated supply chains.[7]
The same review lists IGF-1 LR3 among the IGF-1 analogues that people encounter through online self-administration.[7]
Common questions
Is IGF-1 LR3 FDA approved?
The cached Drugs@FDA lookup for IGF-1 LR3 returned no matches.[2]
Is IGF-1 LR3 legal to buy?
It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.
Is IGF-1 LR3 banned by WADA?
Yes. Prohibited by WADA (S2.3), in and out of competition.
Is IGF-1 LR3 legal?
No application, product or register entry for IGF-1 LR3 appears in the cached FDA, Health Canada, Australian or UK searches.[2]
More on IGF-1 LR3
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "IGF-1 LR3" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "IGF-1 LR3" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
- 4Canada: No product found in a Health Canada Drug Product Database search for ingredient "IGF-1 LR3" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
- 5Australia: No approved product found in an ARTG search for "IGF-1 LR3" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
- 6EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
- 7The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026
Found an error? Report a correction.